Literature DB >> 20861472

Identification and functional characterization of malignant hyperthermia mutation T1354S in the outer pore of the Cavalpha1S-subunit.

Antonella Pirone1, Johann Schredelseker, Petronel Tuluc, Elvira Gravino, Giuliana Fortunato, Bernhard E Flucher, Antonella Carsana, Francesco Salvatore, Manfred Grabner.   

Abstract

To identify the genetic locus responsible for malignant hyperthermia susceptibility (MHS) in an Italian family, we performed linkage analysis to recognized MHS loci. All MHS individuals showed cosegregation of informative markers close to the voltage-dependent Ca(2+) channel (Ca(V)) α(1S)-subunit gene (CACNA1S) with logarithm of odds (LOD)-score values that matched or approached the maximal possible value for this family. This is particularly interesting, because so far MHS was mapped to >178 different positions on the ryanodine receptor (RYR1) gene but only to two on CACNA1S. Sequence analysis of CACNA1S revealed a c.4060A>T transversion resulting in amino acid exchange T1354S in the IVS5-S6 extracellular pore-loop region of Ca(V)α(1S) in all MHS subjects of the family but not in 268 control subjects. To investigate the impact of mutation T1354S on the assembly and function of the excitation-contraction coupling apparatus, we expressed GFP-tagged α(1S)T1354S in dysgenic (α(1S)-null) myotubes. Whole cell patch-clamp analysis revealed that α(1S)T1354S produced significantly faster activation of L-type Ca(2+) currents upon 200-ms depolarizing test pulses compared with wild-type GFP-α(1S) (α(1S)WT). In addition, α(1S)T1354S-expressing myotubes showed a tendency to increased sensitivity for caffeine-induced Ca(2+) release and to larger action-potential-induced intracellular Ca(2+) transients under low (≤ 2 mM) caffeine concentrations compared with α(1S)WT. Thus our data suggest that an additional influx of Ca(2+) due to faster activation of the α(1S)T1354S L-type Ca(2+) current, in concert with higher caffeine sensitivity of Ca(2+) release, leads to elevated muscle contraction under pharmacological trigger, which might be sufficient to explain the MHS phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861472      PMCID: PMC3006335          DOI: 10.1152/ajpcell.00008.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  43 in total

1.  Evidence for genetic heterogeneity of malignant hyperthermia susceptibility.

Authors:  T Deufel; A Golla; D Iles; A Meindl; T Meitinger; D Schindelhauer; A DeVries; D Pongratz; D H MacLennan; K J Johnson
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

2.  Intramembrane charge movement restored in dysgenic skeletal muscle by injection of dihydropyridine receptor cDNAs.

Authors:  B A Adams; T Tanabe; A Mikami; S Numa; K G Beam
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

3.  Functional impact of the ryanodine receptor on the skeletal muscle L-type Ca(2+) channel.

Authors:  G Avila; R T Dirksen
Journal:  J Gen Physiol       Date:  2000-04       Impact factor: 4.086

4.  Faster sequential genetic linkage computations.

Authors:  R W Cottingham; R M Idury; A A Schäffer
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

5.  Kinetic properties of skeletal-muscle-like high-threshold calcium currents in a non-fusing muscle cell line.

Authors:  J M Caffrey
Journal:  Pflugers Arch       Date:  1994-06       Impact factor: 3.657

6.  The alpha 1 and alpha 2 polypeptides of the dihydropyridine-sensitive calcium channel differ in developmental expression and tissue distribution.

Authors:  M E Morton; S C Froehner
Journal:  Neuron       Date:  1989-05       Impact factor: 17.173

7.  Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 locus on chromosome 17q and of the alpha 1, beta 1, and gamma subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect.

Authors:  R Sudbrak; A Golla; K Hogan; P Powers; R Gregg; I Du Chesne; F Lehmann-Horn; T Deufel
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

8.  Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q.

Authors:  R C Levitt; A Olckers; S Meyers; J E Fletcher; H Rosenberg; H Isaacs; D A Meyers
Journal:  Genomics       Date:  1992-11       Impact factor: 5.736

9.  Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.

Authors:  D H MacLennan; C Duff; F Zorzato; J Fujii; M Phillips; R G Korneluk; W Frodis; B A Britt; R G Worton
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

10.  Chlorocresol: an activator of ryanodine receptor-mediated Ca2+ release.

Authors:  F Zorzato; E Scutari; V Tegazzin; E Clementi; S Treves
Journal:  Mol Pharmacol       Date:  1993-12       Impact factor: 4.436

View more
  26 in total

1.  Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor.

Authors:  Jose Miguel Eltit; Roger A Bannister; Ong Moua; Francisco Altamirano; Philip M Hopkins; Isaac N Pessah; Tadeusz F Molinski; Jose R López; Kurt G Beam; Paul D Allen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

2.  CACNA1S haploinsufficiency confers resistance to New World arenavirus infection.

Authors:  Nicolás Sarute; Susan R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

3.  Orthograde dihydropyridine receptor signal regulates ryanodine receptor passive leak.

Authors:  José Miguel Eltit; Hongli Li; Christopher W Ward; Tadeusz Molinski; Isaac N Pessah; Paul D Allen; José R Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

4.  Divergent biophysical properties, gating mechanisms, and possible functions of the two skeletal muscle Ca(V)1.1 calcium channel splice variants.

Authors:  Petronel Tuluc; Bernhard E Flucher
Journal:  J Muscle Res Cell Motil       Date:  2011-11-05       Impact factor: 2.698

5.  Congenital myopathy results from misregulation of a muscle Ca2+ channel by mutant Stac3.

Authors:  Jeremy W Linsley; I-Uen Hsu; Linda Groom; Viktor Yarotskyy; Manuela Lavorato; Eric J Horstick; Drew Linsley; Wenjia Wang; Clara Franzini-Armstrong; Robert T Dirksen; John Y Kuwada
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-21       Impact factor: 11.205

6.  Functional and structural characterization of a novel malignant hyperthermia-susceptible variant of DHPR-β1a subunit (CACNB1).

Authors:  Claudio F Perez; Jose M Eltit; Jose R Lopez; Dóra Bodnár; Angela F Dulhunty; Shouvik Aditya; Marco G Casarotto
Journal:  Am J Physiol Cell Physiol       Date:  2017-12-06       Impact factor: 4.249

7.  Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia.

Authors:  José M Eltit; Xudong Ding; Isaac N Pessah; Paul D Allen; José R Lopez
Journal:  FASEB J       Date:  2012-11-16       Impact factor: 5.191

8.  Using exome data to identify malignant hyperthermia susceptibility mutations.

Authors:  Stephen G Gonsalves; David Ng; Jennifer J Johnston; Jamie K Teer; Peter D Stenson; David N Cooper; James C Mullikin; Leslie G Biesecker
Journal:  Anesthesiology       Date:  2013-11       Impact factor: 7.892

Review 9.  Ca(V)1.1: The atypical prototypical voltage-gated Ca²⁺ channel.

Authors:  Roger A Bannister; Kurt G Beam
Journal:  Biochim Biophys Acta       Date:  2012-09-13

10.  JP-45/JSRP1 variants affect skeletal muscle excitation-contraction coupling by decreasing the sensitivity of the dihydropyridine receptor.

Authors:  Toshimichi Yasuda; Osvaldo Delbono; Zhong-Min Wang; Maria L Messi; Thierry Girard; Albert Urwyler; Susan Treves; Francesco Zorzato
Journal:  Hum Mutat       Date:  2012-10-11       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.